Anticoagulant News and Research

RSS
Adherence to guideline-related therapies can reduce heart failure patients' mortality rate

Adherence to guideline-related therapies can reduce heart failure patients' mortality rate

Regado's REG1 system Phase 2b trial results presented at i2 Summit

Regado's REG1 system Phase 2b trial results presented at i2 Summit

PGXL to utilize AutoGenomics' automated INFINITI analyzer for personalized medicine applications

PGXL to utilize AutoGenomics' automated INFINITI analyzer for personalized medicine applications

Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

Merck to return rights for betrixaban to Portola

Merck to return rights for betrixaban to Portola

Dabigatran etexilate cost-effective compared to current care for stroke prevention in AF patients

Dabigatran etexilate cost-effective compared to current care for stroke prevention in AF patients

Alexion joins EURORDIS, NORD and medical communities to observe Rare Disease Day 2011

Alexion joins EURORDIS, NORD and medical communities to observe Rare Disease Day 2011

Study: Heparin plays a key role in mast cell-driven allergic and inflammatory reactions

Study: Heparin plays a key role in mast cell-driven allergic and inflammatory reactions

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

Tifacogin administration shows no treatment benefit in patients with severe CAP

Tifacogin administration shows no treatment benefit in patients with severe CAP

Study: Ventilator-associated pneumonia infections drop by 70% in Michigan hospitals

Study: Ventilator-associated pneumonia infections drop by 70% in Michigan hospitals

JTH publishes positive TB-402 Phase II trial results for VTE treatment after orthopaedic surgery

JTH publishes positive TB-402 Phase II trial results for VTE treatment after orthopaedic surgery

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

PolyMedix commences PMX-60056 Phase 2 clinical trial in patients undergoing PCI

PolyMedix commences PMX-60056 Phase 2 clinical trial in patients undergoing PCI

DE-MRI holds promise for predicting risks of strokes

DE-MRI holds promise for predicting risks of strokes

Pharmacist-directed anticoagulation service improves quality of care for HIT patients

Pharmacist-directed anticoagulation service improves quality of care for HIT patients

Scientists discover how stressed cells boost  thrombin production

Scientists discover how stressed cells boost thrombin production

Scientists discover how stressed cells boost production of key blood-clotting factor, thrombin

Scientists discover how stressed cells boost production of key blood-clotting factor, thrombin

PhRMA: 299 medicines under development for prevention and treatment of heart disease and stroke

PhRMA: 299 medicines under development for prevention and treatment of heart disease and stroke

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.